Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 266-268
DOI: 10.4103/ijmpo.ijmpo_141_18
Practitioner Section

Multiple Inherited Schwannomas, Meningiomas, and Ependymomas Syndrome in an Adult Patient

Vijay Parshuram Raturi
Department of Radiotherapy, King George Medical University, Lucknow, Uttar Pradesh, India
,
Rahul Singh
Department of Radiotherapy, King George Medical University, Lucknow, Uttar Pradesh, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
   Permissions and Reprints

Abstract

Neurofibromatosis type 2 (NF2) is also known as multiple inherited schwannomas, meningiomas, and ependymomas (MISME) syndrome. Mutation in NF2 gene is the cause for MISME syndrome. We are reporting here a case of MISME syndrome with triple tumor in a 30-year-old male patient who presented with the chief complaints of spastic paraparesis, bowel and bladder incontinence, and decreased vision in the right eye.

Keywords

Ependymoma - meningioma - multiple inherited schwannomas - and neurofibromatosis


Publication History

Received: 25 June 2018

Accepted: 12 September 2018

Article published online:
23 May 2021

© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jin X, He J, Wang D, Zhang X, Wu Y, Liu H. et al. MISME syndrome with triple tumors affecting cervical spinal cord. Neurol Cases 2014; 1: 2374-3522
    Google Scholar
  • 2 Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM. et al. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet A 2010; 152A: 327-32
    CrossrefPubMedGoogle Scholar
  • 3 Baser ME, Evans DG. Lack of sex-ratio distortion in neurofibromatosis 2. Am J Med Genet 2000; 95: 292
    CrossrefPubMedGoogle Scholar
  • 4 Evans DG. Neurofibromatosis type 2 (NF2): A clinical and molecular review. Orphanet J Rare Dis 2009; 4: 16
    CrossrefPubMedGoogle Scholar
  • 5 Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J. et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000; 54: 71-6
    CrossrefPubMedGoogle Scholar
  • 6 Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A. et al. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia 2008; 10: 1204-12
    CrossrefPubMedGoogle Scholar
  • 7 Chen AF, Samy RN, Gantz BJ. Cerebellopontine angle tumor composed of Schwann and meningeal proliferations. Arch Otolaryngol Head Neck Surg 2001; 127: 1385-9
    CrossrefPubMedGoogle Scholar
  • 8 Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z. et al. Neurofibromatosis type 2. Lancet 2009; 373: 1974-86
    CrossrefPubMedGoogle Scholar
  • 9 Walter J, Kuhn SA, Brodhun M, Reichart R, Kalff R. Pulmonary meningioma and neurinoma associated with multiple CNS tumours in a patient with neurofibromatosis type 2. Clin Neurol Neurosurg 2009; 111: 454-9
    CrossrefPubMedGoogle Scholar
  • 10 Stumpf DA, Alksne JF, Annegers JF. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-8
    CrossrefPubMedGoogle Scholar
  • 11 Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE. et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278: 51-7
    CrossrefPubMedGoogle Scholar
  • 12 National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13 1991. The consensus development panel. Arch Neurol 1994; 51: 201-7
    CrossrefPubMedGoogle Scholar